1-12 of 12
R Maher
Close
Sort by
Journal Articles

A Retrospective Comparison of Hypomethylating Agent in Combination with Venetoclax Versus Liposomal Daunorubicin and Cytarabine in Frontline Treatment of Acute Myeloid Leukemia

Keri R. Maher, Ian M. Bouligny
Journal: Blood
Blood (2021) 138 (Supplement 1): 2336.
https://doi.org/10.1182/blood-2021-153918
Published: 2021
Journal Articles

Outcomes of Induction with Venetoclax in Combination with Decitabine, Azacitidine, or Low-Dose Cytarabine for Treatment of AML: A Real-World Retrospective Analysis

Ian M. Bouligny, Keri R. Maher
Journal: Blood
Blood (2021) 138 (Supplement 1): 2335.
https://doi.org/10.1182/blood-2021-153738
Published: 2021
Journal Articles

Minority Health Disparities in Acute Myeloid Leukemia: A Metropolitan, Single-Center Retrospective Analysis

Keri R. Maher, Ian M. Bouligny
Journal: Blood
Blood (2021) 138 (Supplement 1): 1987.
https://doi.org/10.1182/blood-2021-153642
Published: 2021
Journal Articles

Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia

Ian M. Bouligny, Keri R. Maher
Journal: Blood
Blood (2021) 138 (Supplement 1): 4424.
https://doi.org/10.1182/blood-2021-153690
Published: 2021
Journal Articles

The Impact of Molecular and Cytogenetic Clonal Evolution on Survival in Relapsed/Refractory AML

Ian M. Bouligny, Keri R. Maher
Journal: Blood
Blood (2021) 138 (Supplement 1): 4452.
https://doi.org/10.1182/blood-2021-153194
Published: 2021
Journal Articles

Outcomes of High-Intensity Versus Low-Intensity Induction in Elderly Patients with AML: A Retrospective Analysis of Real-World Outcomes

Ian M. Bouligny, Keri R. Maher
Journal: Blood
Blood (2021) 138 (Supplement 1): 4386.
https://doi.org/10.1182/blood-2021-153526
Published: 2021
Journal Articles

Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting

Leila Jafari, Jubair Hussain, Ravi Krishnadasan, MD, Keri R Maher, DO, Faiz Anwer, MD, Emad Elquza, MD MBA, Christopher Campen, PharmD, Lauren Sanders, PharmD, Alyssa Henglefelt, PharmD, Alicia Ortega, PharmD, Ali McBride, PharmD,MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2153.
https://doi.org/10.1182/blood-2019-132121
Published: 2019
Journal Articles

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

Pavan Tenneti, MD, Keri R Maher, DO, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Saad Ullah Malik, MD, Warda Faridi, MD, Faiz Anwer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5182.
https://doi.org/10.1182/blood-2018-99-115810
Published: 2018
Journal Articles

Elderly AML: A Five-Year Retrospective Review on Prognostic Features

Akshay Amaraneni, MD, Jennifer Segar, MD, Trace Bartels, BS, Onyemaechi Okolo, MD, Andrew C Rettew, DO, Ali McBride, PharmD, MS, Faiz Anwer, MD, Keri R Maher, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 5187.
https://doi.org/10.1182/blood-2018-99-111418
Published: 2018
Journal Articles

Safety and Efficacy of Plerixafor on a Convenient Dose Schedule to Facilitate Outpatient Hematopoietic Stem Cell Collection for Autologous Hematopoietic Transplantation

Christopher Chen, MD MBA, Andrew M. Yeager, MD, Faiz Anwer, MD, Ali McBride, PharmD, MS, Keri R Maher, DO, Christopher Campen, PharmD
Journal: Blood
Blood (2016) 128 (22): 5736.
https://doi.org/10.1182/blood.V128.22.5736.5736
Published: 2016
Journal Articles

Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma

Michael S. Wiesener, Melchior Seyfarth, Christina Warnecke, Jan Steffen Jürgensen, Christian Rosenberger, Neil V. Morgan, Eamonn R. Maher, Ulrich Frei, Kai-Uwe Eckardt
Journal: Blood
Blood (2002) 99 (10): 3562–3565.
https://doi.org/10.1182/blood.V99.10.3562
Published: 2002
Journal Articles

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

D Przepiorka, C Ippoliti, I Khouri, M Woo, R Mehra, D Le Bherz, S Giralt, J Gajewski, H Fischer, H Fritsche, AB Deisseroth, K Cleary, R Champlin, K Besien, B Andersson, R Maher, W Fitzsimmons
Journal: Blood
Blood (1996) 88 (11): 4383–4389.
https://doi.org/10.1182/blood.V88.11.4383.4383
Published: 1996